Spelling suggestions: "subject:"ataxia."" "subject:"staxia.""
101 |
Functional analysis of the CNS-specific F-box protein FBXO41 in cerebellar development / Functional analysis of the CNS-specific F-box protein FBXO41 in cerebellar developmentMukherjee, Chaitali 08 June 2015 (has links)
No description available.
|
102 |
Joint Center Movement Analysis and 3D Motion Modeling of Upper Arm - Comparison of Several Algorithms with the Visual 3-D ProgramJoseph, Leena 01 January 2005 (has links)
600 out of every 100,000 people in the United States today suffer from some form of cerebellar disease that causes major abnormalities in the equilibrium and aligned, coordinated movement of the body. Hence it becomes essential to diagnose the extent of the movement and gait disorder and provide required therapy to the patients. Various developments have been made in the designing and application of interactive software system for body positioning. Object oriented design techniques are used in the field of software engineering for interactive geometric representation of system behavior. Motion analysis of the upper and lower extremities of the body could be beneficial in the diagnosis and therapy of numerous orthopedic and neurological ailments. Mathematical models of neuro-musculoskeletal dynamics establish a scientific basis for movement analysis. As mentioned above, an interactive geometric representation of the system behavior is an important diagnostic tool in orthopedic therapy. This realistic depiction of the human body with respect to the model is a very effective diagnostic tool for clinicians. There are existing biomechanical modeling tools like Visual 3-D etc, that are used for motion analysis. Visual 3-D was developed by the movement disorders laboratory at NIH. The preferred method is to place markers on the segments and calculate the joint center locations using a rigid-body assumption. However studies have shown that markers on the joint centers are subject to artifact (skin movement). Moreover, very few details are provided on the algorithm used by Visual 3-D, and no "fixes" are provided for marker dropout. This project aims at testing the accuracy of existing biomechanical movement analysis software Visual 3D by calculating the rigid body motion from the spatial co-ordinates of the markers clusters on the subject's upper extremities. This project tries to emulate their approach in a simple and effective manner and at the same time validate the approach by testing it by three different methods by calculating the elbow and wrist locations during a forward reaching motion of the subject. A mathematical model is developed by determining a relationship between the projections of a particular point in two different planes or on a single plane in two different directions [Kinzel, G.L. et. al. 1972]. The computer simulations are performed using MATLAB to calculate the lunematical parameters from the co-ordinates of projections of markers placed on the upper extremities of the subject's body. This relation will aid in quantitative motion analysis of the upper extremities in the rehabilitation setting. This can be extended to in-depth gait analysis of the lower extremities too. This type of biomechanical movement analysis allows us to understand the dynamic implications of a particular impairment, such as spasticity or weakness, in a particular muscle group.
|
103 |
Vliv hluboké masáže chodidla na posturální stabilitu u pacientů se spinocerebelární ataxií / Effect of deep foot massage on postural stability in patients with spinocerebellar ataxiaHlaváčková, Tereza January 2013 (has links)
Introduction: Spinocerebellar ataxia (SCA) is currently defined as a group of diseases with progressive cerebellar syndrome, which manifests distinctively by ataxic stance and gait. In patients with SCA, deterioration of postural control occurs due to changes of pathophysiological degenerative nervous system. Control of postural stability is significantly influenced by somatosensory afferentation of soft tissue of foot. The work objective is to determine the effect of deep foot massage on postural stability in the group of patients and to compare obtained results with experiments without deep foot massage. Methods: Seven patients of the Clinic Rehabilitation at the Faculty Hospital, Prague Motol (average age 51.9 ± 13.9 years, 5 men, and 2 women) with SCA and clinical signs of cerebellar ataxia were participated in this study. All patients were examined using posturography before and after application of deep foot massage. Measurements were conducted on a firm surface, foam pad with open and closed eyes. Length of COP trajectory, COP area and COP velocity were measured. Results: Significantly lower values of the length and COP velocity were found on the foam pad with closed eyes, when the deep foot massage was applied. Experiments without applications of the deep foot massage did not show any...
|
104 |
Caractérisation phénotypique, comportementale et neurochimique, de la souris mutante ataxique scrambler (Dab1scm) / Phenotypic, behavioral and neurochemical characterization of the mutant ataxic mice scrambler (Dab1scm)Jacquelin, Cécile 10 December 2015 (has links)
La souris scrambler (Dab1scm) est un mutant ataxique cérébelleux qui présente une mutation naturelle du gène mdab1, codant pour une protéine intracellulaire nécessaire à la voie de signalisation de la rééline. Cette protéine joue un rôle crucial dans la mise place et la plasticité des structures laminées telles que le cortex cérébral, l’hippocampe ou le cervelet. Notre objectif a été de caractériser le phénotype comportemental et neurochimique de la souris scrambler au cours du développement post-natal et à l’âge adulte. Les premiers signes de l’ataxie cérébelleuse sont observables dès 8 jours et sont majorés au cours des 2ème et 3ème semaines de vie post-natale. A l’âge adulte, la souris se caractérise par un trouble important de la coordination motrice et une hyperactivité locomotrice exacerbée et stéréotypée (comportement de rotation) lorsque l’animal est placé en milieu aquatique. Les tests du labyrinthe aquatique de Morris et de l’alternance spontanée mettent en évidence des déficiences possiblement causées par un trouble du guidage visuo-moteur et la désinhibition comportementale. Chez ces souris, l’activité métabolique régionale évaluée par le marquage de la cytochrome oxydase est relativement préservée dans le cervelet ; elle est en revanche altérée dans diverses régions du tronc cérébral qui lui sont associées ainsi que dans l’hippocampe et certaines régions corticales. Le comportement de rotation stéréotypé et l’hyperactivité causés possiblement par un déséquilibre neurochimique acétylcholine/dopamine a été évalué dans un rotamètre avec ou sans injection préalable d’un antagoniste des récepteurs D2. Parallèlement, l’innervation cholinergique du système nerveux central, révélée par l’activité de l’acétylcholinestérase était diminuée dans la substance noire pour laquelle nous avons observé une désorganisation et une perte partielle des neurones dopaminergiques. Bien que les atteintes multiples compliquent l’étude structuro- fonctionnelle de ce mutant, nos résultats ont permis de préciser le phénotype scrambler en le comparant aux autres mutants de la voie de la rééline. Ces mutants font l’objet aujourd’hui d’un intérêt croissant pour la modélisation non seulement de l’ataxie mais également de certaines maladies neurologiques et neuro-psychiatriques comme l’autisme et la schizophrénie / The Dab1scm scrambler mice is a cerebellar ataxic mutant spontaneously mutated for a gene encoding a protein of the reelin signaling pathway involved in the development and the plasticity of laminated structures such as the neocortex, the hippocampus, and the cerebellum. Our objective was to characterize the behavioral and neurochemical phenotype of the scrambler mice during postnatal developmental and adult stages. The first signs of cerebellar ataxia are observable as early as 8 days and increase during the 2nd and 3rd weeks of postnatal life. Adult mouse is characterized by a significant disturbance of motor coordination and a locomotor hyperactivity which increases ans becomes stereotyped (circling) when the animal was placed in water. Morris water maze and spontaneous alternation highlight deficiencies possibly caused by disorder of visuomotor control and disinhibitory processes. Brain regional metabolic activity measured by cytochrome oxidase is relatively preserved in the mutant cerebellum. However, it is impaired in various connected regions of the brainstem as well as in the hippocampus and some cortical regions. Circling behavior and hyperactivity, possibly caused by a neurochemical imbalance between acetylcholine and dopamine, were evaluated in a rotameter with or whithout prior injection of D2 receptor antagonist. In parallel, cholinergic innervation of the central nervous system measured by acetylcholinesterase activity is lower in the substantia nigra for which a partial disruption and loss of dopaminergic neurons is observed. Although the multiple alterations complicate the structuro-fonctional study of this mutant, results have clarified the scrambler phenotype by comparison with others mutants of the reelin pathway. This mutants are now subject to a growing interest in not only ataxia modeling but also some neurological and neuropsychiatric diseases
|
105 |
The cellular phenotype of the neurodegenerative disease autosomal recessive spastic ataxia of Charlevoix-SaguenayBradshaw, Teisha Y. January 2014 (has links)
Autosomal recessive spastic ataxia of Charlevoix Saguenay (ARSACS) is an early onset neurodegenerative disorder resulting from mutations in the SACS gene that encodes the protein sacsin. Sacsin is a 520kDa multi-domain protein localised at the cytosolic face of the outer mitochondrial membrane with suggested roles in proteostasis and most recently in the regulation of mitochondrial morphology. An excessively interconnected mitochondrial network was observed as a consequence of reduced levels of sacsin protein following SACS knockdown in neuroblastoma cells as well as in an ARSACS patient carrying the common Quebec homozygous SACS mutation 8844delT. Moreover, it was suggested that sacsin has a role in mitochondrial fission as it was found to interact with mitochondrial fission protein Dynamin related protein 1 (Drp1). The aim of this thesis was to explore sacsin’s role in the regulation of mitochondrial morphology and dynamics in non-Quebec ARSACS patients and sacsin knockdown fibroblasts. This study shows that loss of sacsin function promotes a more interconnected mitochondrial network in non-Quebec ARSACS patients and in sacsin knockdown fibroblasts. Moreover, recruitment of the essential mitochondrial fission protein Drp1 to the mitochondria was significantly reduced in ARSACS patient cells and in sacsin knockdown fibroblasts. This reduced recruitment of Drp1 to mitochondria also occurred when cells were treated to induce mitochondrial fission. Furthermore, both the size and intensity of Drp1 foci localised to the mitochondria were significantly reduced in both sacsin knockdown and patient fibroblasts. Finally, reduced ATP production, decreased respiratory capacity of mitochondria and an increase in mitochondrial reactive oxygen species demonstrated impaired mitochondrial function in ARSACS patient and sacsin knockdown fibroblasts. These results suggest a role for sacsin in the stabilisation or recruitment of cytoplasmic Drp1 to prospective sites of mitochondrial fission similar to that observed by other mitochondrial fission accessory proteins.
|
106 |
The neurodegenerative disease Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS) : cellular defects due to loss of sacsin functionDuncan, Emma Jane January 2016 (has links)
Sacsin, which is mutated in the neurodegenerative disease Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS), is a 520 kDa modular protein with regions of homology to molecular chaperones and domains linking to the ubiquitin proteasome system. This suggests a role in proteostasis. Previously, sacsin has been shown to partially localise with mitochondria, and loss of sacsin results in elongated and dysfunctional mitochondria. Moreover, alterations in neurofilaments have recently been reported in a mouse model of ARSACS. Despite these findings, pathophysiological mechanisms of ARSACS are poorly understood. The aim of this thesis was to elucidate the cellular role of sacsin by determining how loss of its function leads to the observed mitochondrial and intermediate filament defects. This hoped to shed light on the mechanism of disease in ARSACS. The results indicate that the mitochondrial elongation seen in ARSACS is likely due to reduced mitochondrial localisation of the essential fission factor DRP1. This may be mediated by loss of function of a complex involving sacsin and dynactin-6, a subunit of the dynein-dynactin motor complex, which has previously been shown to be required for DRP1 mitochondrial recruitment. DRP1-mediated mitochondrial fission is necessary for mitochondrial quality control; hence a disruption to mitochondrial quality control is likely to occur in sacsin deficient cells, which may explain the mitochondrial dysfunction in ARSACS. Furthermore, sacsin null cells display a dramatic collapse and perinuclear bundling of the vimentin intermediate filament network. This is coupled with the displacement of cellular organelles, particularly mitochondria, early endosomes and the Golgi, which accumulate at the periphery of the vimentin bundle. These are characteristic features of aggresome formation, indicating an aggregation of misfolded protein, which occurs due to disrupted proteostasis. Further supporting this, the proteostasis components ubiquitin, HSP70, LAMP2 and p62 are recruited to the perinuclear vimentin bundles. In summary, the findings of this thesis indicate a role for sacsin in mitochondrial and protein quality control, the dysfunction of which is likely to be particularly detrimental in neurons. Mitochondrial dysfunction along with protein misfolding and aggregation are implicated in many neurodegenerative diseases, and ARSACS is no exception.
|
107 |
Novel Roles of Ataxia Telangiectasia Mutated (ATM) in DNA Repair and Tumor SuppressionYamamoto, Kenta January 2015 (has links)
Mammalian cells possess a variety of different DNA repair pathways, which work together to safeguard genomic integrity upon encountering different types of DNA damage. Among all lesions, DNA double-strand breaks (DSBs) are most toxic and, if left unrepaired, results in loss of genetic information and genomic instability- a hallmark of tumorigenesis. Ataxia Telangiectasia Mutated (ATM) is a protein kinase, a master regulator of the DNA damage response, and is activated upon the formation of DSBs. ATM senses DNA DSBs through its accessory proteins and functions as a transducer of the DNA damage response (DDR), which entails the activation of genes involved in DNA repair, cell cycle checkpoint, and apoptosis. Consequently, loss of ATM results in increased genomic instability and compromised checkpoint regulation. Moreover, loss of ATM has been reported in various human cancers, and Atm-deficient mice uniformly develop thymic lymphomas, highlighting its role as a tumor suppressor.
Although ATM has been extensively studied, much of its known functions to date pertained to its kinase activity, and the structural function of ATM remains elusive. To investigate whether ATM possesses structural functions beyond its kinase activity, we generated a mouse model expressing kinase-dead (KD) ATM protein. Intriguingly, while Atm-/- are viable, AtmKD/KD and AtmKD/- mice were embryonic lethal and AtmKD/KD and AtmKD/- cells displayed greater genomic instability compared to ATM-null cells, suggesting that the presence of the ATM KD protein blocks additional DNA repair pathways that are not affected in ATM-null cells. In this context, we identified defects in homologous recombination, resolution of Camptothecin (CPT)-induced Topoisomerase-I lesions, and replication progression specifically in AtmKD/- cells beyond those observed in Atm-/-. Mouse model expressing KD ATM (AtmKD/-) in hematopoietic stem cells (HSCs) developed thymic lymphomas faster and more frequently than the corresponding model with the ATM-null HSCs, which was associated with increased genomic instability and loss of tumor-suppressor Pten. In collaboration with others, we showed that the majority of tumor-associated ATM mutations reported in TCGA are missense mutations and are highly enriched in the kinase domain, while Ataxia-Telangiectasia (A-T) associated germline ATM mutations are almost always truncating mutations leading to complete loss of ATM protein. This result suggests that ATM KD protein might be expressed in a significant fraction of human cancer. These results, for the first time, identified a previously unknown phosphorylation-dependent, structural function of ATM in the maintenance of genomic integrity and tumor suppression. Furthermore, the tumorigenicity and vulnerability to particular DNA damaging agents caused by the expression of the ATM KD protein relative to the loss of ATM highlight the importance of distinguishing the types of ATM mutations in tumors, and provide novel insights into the clinical use of specific ATM kinase inhibitors, as well as the prognosis and treatments of ATM-mutated cancers.
ATM has been reported to be frequently inactivated in human B-cell lymphomas, including up to 50% Mantle Cell Lymphoma (MCL), which represents around 6% of all Non-Hodgkins Lymphomas (NHLs). MCL is characterized by the recurrent t(11;14)(q13;q32) translocation, which juxtaposes CCND1/BCL-1 to the IGH enhancer, leading to deregulated expression of CyclinD1 (CCND1). However, CyclinD1 overexpression in B cells alone is not sufficient to induce MCL in mouse models, and the role of ATM in the suppression of B-cell lymphomas is not well understood, in part due to the lack of ATM-deficient mature B-cell lymphoma models. To address this, we generated a mouse model that combines conditional deletion of ATM specifically in early progenitor B-cells via Mb1cre, and overexpressing CyclinD1 in lymphoid cells via EµCyclinD1 transgene. While ATM loss alone resulted in the development of indolent, clonal, mature B-cell lymphoma, combined ATM-loss and CyclinD1 overexpression accelerated and increased the incidence of B-cell lymphoma. Furthermore, ATM-loss combined with CyclinD1 overexpression led to greater genomic instability and the expansion of naïve ATM-deficient B-cells in the spleen. This study, for the first time, developed an ATM-deficient B-cell lymphoma model and demonstrated a synergistic function of ATM and CyclinD1 in pre-GC B-cell proliferation and lymphomagenesis. Furthermore, the mice described here provide a prototypic animal model to study the pathogenesis of human MCL, for which there are no suitable mouse models.
|
108 |
Ataxies cérébelleuses héréditaires : identification de gènes responsables, description clinique et stratégie diagnostique / Cerebellar ataxias : identification of responsible genes, clinical description and diagnostic strategyRenaud, Mathilde 24 May 2017 (has links)
Les ataxies cérébelleuses héréditaires sont des pathologies neuro-dégénératives rares, hétérogènes, complexes affectant le cervelet et parfois la moelle épinière et/ou les nerfs périphériques. Elles se transmettent sur le mode autosomique récessif (ARCA), dominant (SCA) ou lié à l’X. Les objectifs de cette thèse de sciences étaient la description phénotypique d’ataxies cérébelleuses héréditaires, la mise en évidence de corrélations du génotype au phénotype et la description de stratégies diagnostiques pour mettre en évidence ces pathologies rares.Grâce à nos résultats, nous avons pu élargir le spectre phénotypique clinique, biologique, radiologique d’ataxies cérébelleuses héréditaires connues : Fragile X Tremor Ataxia Syndrome (FXTAS), ataxie récessive lentement progressive liée au gène PEX 10 impliqué dans la biogénèse du peroxysome, ataxie avec apraxie oculomotrice de type 1 (AOA1). Nous avons pu mettre en évidence des corrélations du génotype au phénotype dans AOA1 et montré que l’âge moyen de début était plus élevé et que la pathologie était moins sévère chez les patients avec au moins un faux sens (p <0,01) par rapport aux patients avec deux mutations tronquantes. Nous avons réussi également à établir un algorithme pour faciliter le diagnostic des ataxies cérébelleuses autosomiques récessives et aider à l’interprétation du séquençage à haut débit. Il est important dans ce type de pathologies rares de pouvoir établir au maximum un diagnostic moléculaire afin de guider le conseil génétique et mettre en évidence les ataxies accessibles à une thérapeutique. / Hereditary cerebellar ataxias are a group of rare and heterogeneous neurodegenerative diseases. The transmission mode is recessive, dominant or X-linked. Our objectives were to better describe the phenotype of some inherited ataxias, to provide genotype-phenotype correlations and to improve the diagnostic strategies for these rare diseases. We enlarged the clinical, biological, radiological phenotype of Fragile X Tremor Ataxia Syndrome (FXTAS), recessive ataxia due to PEX10 related peroxisomal biogenesis disorders, ataxia with oculomotor apraxia type 1 (AOA1). We showed genotype-phenotype correlations in AOA1 patients: mean age at onset was higher with at least one missense mutation. A ranking algorithm has been created to predicting the molecular diagnoses of recessive cerebellar ataxia in order to guide the diagnosis and facilitate interpretation of next generation sequencing. The establishment of a molecular diagnosis is important in this type of rare pathologies to guide the genetic counseling and to diagnosis the ataxias accessible to a treatment.
|
109 |
Toward understanding the role of protein context in the polyglutamine disease, SCA3Harris, Ginny Marie 01 May 2011 (has links)
The polyglutamine diseases are a clinically heterogeneous group of inherited neurodegenerative disorders caused by expansion of polyglutamine-encoding (CAG)n trinucleotide repeats within the disease genes. It is increasingly clear that the amino acid sequences flanking the polyglutamine expansion in each disease protein, i.e. the specific protein context, contribute to selective neuronal toxicity by influencing the behavior of the disease protein within selectively vulnerable neuronal populations. In the studies described here, I explore the role that protein context plays in the polyglutamine disease, Spinocerebellar ataxia type 3 (SCA3). Toward this end, I utilize biochemical, cell-based, and animal models to gain a broader understanding of the SCA3 disease protein, ataxin-3, and generate tools for further exploration of the molecular properties of ataxin-3 that modulate its toxicity during disease.
In Chapter 1, I provide an overview of the recognized polyglutamine diseases, emphasizing the elements of protein context that are distinct among the polyglutamine disease proteins and may contribute to the neuropathological and clinical heterogeneity within this family of diseases. Alternative splicing of the polyglutamine disease gene products adds an additional level of complexity to the tissue-specific protein context of expanded polyglutamine, yet this phenomenon has been underinvestigated. In Chapter 2, I examine the significance of ataxin-3 splice variation. Several minor 5' variants and both known 3' splice variants of ataxin-3, a deubiquitinating enzyme, are expressed at the mRNA level in brain. At the protein level, however, the C-terminal splice isoform with three ubiquitin interacting motifs (3UIM ataxin-3) is the predominant isoform in brain, independent of age or (CAG)n expansion. Although both C-terminal ataxin-3 splice isoforms display similar in vitro deubiquitinating activity, 2UIM ataxin-3 is more prone to aggregate and is more rapidly degraded by the proteasome. These observations demonstrate how alternative splicing of sequences distinct from the polyglutamine-encoding (CAG)n repeat can alter disease-related components of protein context.
Knock-in models of polyglutamine diseases utilize pathogenic (CAG)n expansions within the endogenous genomic, transcript, and protein context to recreate key features of individual polyglutamine diseases. In chapter 3, I describe the creation of the first knock-in mouse model of SCA3. Hemizygous knock-in mice transmit the knock-in allele in Mendelian ratios and broadly express both the expanded Atxn3(Q3KQ82) protein and the wildtype murine Atxn3(Q6) protein. In this chapter, I also compare the gene targeting efficiencies and rates of chromosomal instability of a novel C57BL/6J ES cell line (UMB6JD7) and two well established ES cell lines (W4 and Bruce4.G9). Of these, Bruce4.G9 ES cells proved superior based on lower rates of aneuploidy and the production of germline transmitting chimeras.
Finally, in Chapter 4 I discuss questions and concepts raised during the course of these studies, and suggest avenues of future research aimed at broadening our understanding of ataxin-3 physiology and of protein context-dependent elements in polyglutamine disease pathogenesis.
|
110 |
SK Channel Modulators as Drug Candidates and Pharmacological ToolsOrfali, Razan 14 April 2018 (has links)
The small- and intermediate-conductance Ca2+ activated K + (SK/IK) channels play a fundamental role in the regulation of neurons in the central nervous system. In animal models, SK/IK channel positive modulators have been shown to be effective in reducing the symptoms of neurological diseases such as ataxia. Ataxia is a lethal neurological rare disease characterized by lack of balance and incoordination of muscle movements, often as a result of cerebellar or spinocerebellar neurodegeneration. SK/IK channel modulators have been developed over the past few decades. Currently available modulators are often weak in potency. Lack of knowledge about the binding site for the compounds is the main reason hindering the development of more potent and effective therapeutics targeting SK channels. Dr. Zhang and his colleagues recently discovered the binding pocket for these positive modulators of SK/IK channels. This pocket is located at the interface between the channel and calmodulin. Dr. Zhang and his colleagues performed screening of a large number of compounds in silico, to find those fitting into the binding pocket. I performed electrophysiological recordings to evaluate the efficacy and the potency of these modulators on SK2 channels. We discovered a correlation between the total binding energy values calculated from the structures and the potencies determined from electrophysiological recording.
|
Page generated in 0.0272 seconds